The new edition of ISO 20417 has been published, further clarifying expectations for information supplied with medical devices. Although not yet harmonized, the standard is already relevant in regulatory dialogue and audit preparation.
For manufacturers, this is a good moment to reflect on labeling and IFU strategies and consider how Notified Bodies may reference updated standards when assessing compliance.
In practice, this often means:
• reviewing existing labeling and IFUs against the updated ISO 20417 requirements
• assessing gaps and documenting rationale where changes are not yet implemented
• aligning interpretations across RA, QA and technical teams
• preparing clear justifications for discussions with Notified Bodies and auditors
We know that translating new or non harmonized standards into concrete actions can be challenging—especially when time and resources are limited. Our quality and regulatory experts can help you make this process structured and manageable, supporting smoother regulatory interactions and audit discussions.
